Theriva Biologics, Inc. (TOVX)
0.2481
0.00 (0.00%)
USD |
NYAM |
Sep 02, 16:00
0.2498
0.00 (0.00%)
After-Hours: 06:51
Theriva Biologics Research and Development Expense (TTM) : 5.306M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.306M |
| March 31, 2026 | 5.991M |
| December 31, 2025 | 8.604M |
| September 30, 2025 | 10.36M |
| June 30, 2025 | 10.54M |
| March 31, 2025 | 11.54M |
| December 31, 2024 | 12.03M |
| September 30, 2024 | 13.34M |
| June 30, 2024 | 14.61M |
| March 31, 2024 | 14.79M |
| December 31, 2023 | 14.31M |
| September 30, 2023 | 13.19M |
| June 30, 2023 | 11.75M |
| March 31, 2023 | 12.10M |
| December 31, 2022 | 11.72M |
| September 30, 2022 | 11.43M |
| June 30, 2022 | 10.83M |
| March 31, 2022 | 9.28M |
| December 31, 2021 | 7.801M |
| September 30, 2021 | 6.001M |
| June 30, 2021 | 4.943M |
| March 31, 2021 | 4.614M |
| December 31, 2020 | 5.131M |
| September 30, 2020 | 6.079M |
| June 30, 2020 | 9.309M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.30M |
| December 31, 2019 | 11.08M |
| September 30, 2019 | 11.21M |
| June 30, 2019 | 9.914M |
| March 31, 2019 | 10.89M |
| December 31, 2018 | 11.84M |
| September 30, 2018 | 13.54M |
| June 30, 2018 | 14.84M |
| March 31, 2018 | 16.09M |
| December 31, 2017 | 18.78M |
| September 30, 2017 | 21.76M |
| June 30, 2017 | 24.68M |
| March 31, 2017 | 27.01M |
| December 31, 2016 | 29.11M |
| September 30, 2016 | 31.24M |
| June 30, 2016 | 34.22M |
| March 31, 2016 | 34.57M |
| December 31, 2015 | 32.91M |
| September 30, 2015 | 29.29M |
| June 30, 2015 | 22.94M |
| March 31, 2015 | 18.27M |
| December 31, 2014 | 14.49M |
| September 30, 2014 | 11.96M |
| June 30, 2014 | 9.74M |
| March 31, 2014 | 8.106M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 86.86M |
| Nkarta, Inc. | 89.88M |
| Unicycive Therapeutics, Inc. | 9.609M |
| OnKure Therapeutics, Inc. | 46.54M |
| ACADIA Pharmaceuticals, Inc. | 331.01M |